Apellis Pharmaceuticals, Inc. (APLS) vs Blueprint Medicines Corporation (BPMC)
Detailed comparison between Apellis Pharmaceuticals, Inc., Blueprint Medicines Corporation.Total Return (%)
Apellis Pharmaceuticals, Inc. (APLS)Blueprint Medicines Corporation (BPMC)
Which stock do you think will perform better?
Apellis Pharmaceuticals, Inc.
APLS
Blueprint Medicines Corporation
BPMC
| Metric | Apellis Pharmaceuticals, Inc. (APLS) | Blueprint Medicines Corporation (BPMC) |
|---|---|---|
| Current Price | $20.11 | $129.46 |
| Change | 0.07 (0.37%) | 0.00 (0.00%) |
| Market Cap | $2.53B | $8.37B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -23.95 | -137.72 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $42.47 | $129.55 |
| 52-Week Low | $16.10 | $73.04 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-1.80 | $-2.51 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| APLS | 13.71% | -33.24% | -47.04% | -40.23% | 43.37% | 43.37% |
| BPMC | 0.98% | 15.63% | 12.60% | 65.06% | 308.26% | 308.26% |